Table of Contents Global Benign Prostatic Hyperplasia Devices Professional Survey Report Report 2022, Forecast to 2027 1 Market Study Overview 1.1 Study Objectives 1.2 Benign Prostatic Hyperplasia Devices Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research Methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 Benign Prostatic Hyperplasia Devices Segment by Type 2.1.1 Drugs 2.1.2 Devices 2.2 Market Analysis by Application 2.2.1 Hospitals 2.2.2 Clinics 2.2.3 Others 2.3 Global Benign Prostatic Hyperplasia Devices Market Comparison by Regions (2017-2027) 2.3.1 Global Benign Prostatic Hyperplasia Devices Market Size (2017-2027) 2.3.2 North America Benign Prostatic Hyperplasia Devices Status and Prospect (2017-2027) 2.3.3 Europe Benign Prostatic Hyperplasia Devices Status and Prospect (2017-2027) 2.3.4 Asia-pacific Benign Prostatic Hyperplasia Devices Status and Prospect (2017-2027) 2.3.5 South America Benign Prostatic Hyperplasia Devices Status and Prospect (2017-2027) 2.3.6 Middle East & Africa Benign Prostatic Hyperplasia Devices Status and Prospect (2017-2027) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): Benign Prostatic Hyperplasia Devices Industry Impact 2.5.1 Benign Prostatic Hyperplasia Devices Business Impact Assessment - Covid-19 2.5.2 Market Trends and Benign Prostatic Hyperplasia Devices Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Manufacturer (2017-2022) 3.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Manufacturer (2017-2022) 3.3 Global Benign Prostatic Hyperplasia Devices Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 Benign Prostatic Hyperplasia Devices Manufacturer Market Share 3.5 Top 10 Benign Prostatic Hyperplasia Devices Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into Benign Prostatic Hyperplasia Devices Market 3.7 Key Manufacturers Benign Prostatic Hyperplasia Devices Product Offered 3.8 Mergers & Acquisitions Planning 4 Analysis of Benign Prostatic Hyperplasia Devices Industry Key Manufacturers 4.1 Pfizer 4.1.1 Company Details 4.1.2 Pfizer Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.1.3 Pfizer Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.1.4 Main Business Overview 4.1.5 Pfizer News 4.2 Teva Pharmaceutical 4.2.1 Company Details 4.2.2 Teva Pharmaceutical Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.2.3 Teva Pharmaceutical Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.2.4 Main Business Overview 4.2.5 Teva Pharmaceutical News 4.3 Boston Scientific 4.3.1 Company Details 4.3.2 Boston Scientific Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.3.3 Boston Scientific Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.3.4 Main Business Overview 4.3.5 Boston Scientific News 4.4 Sanofi 4.4.1 Company Details 4.4.2 Sanofi Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.4.3 Sanofi Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.4.4 Main Business Overview 4.4.5 Sanofi News 4.5 Allergan 4.5.1 Company Details 4.5.2 Allergan Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.5.3 Allergan Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.5.4 Main Business Overview 4.5.5 Allergan News 4.6 GlaxoSmithKline 4.6.1 Company Details 4.6.2 GlaxoSmithKline Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.6.3 GlaxoSmithKline Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.6.4 Main Business Overview 4.6.5 GlaxoSmithKline News 4.7 Eli Lilly 4.7.1 Company Details 4.7.2 Eli Lilly Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.7.3 Eli Lilly Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.7.4 Main Business Overview 4.7.5 Eli Lilly News 4.8 Cardinal Health 4.8.1 Company Details 4.8.2 Cardinal Health Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.8.3 Cardinal Health Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.8.4 Main Business Overview 4.8.5 Cardinal Health News 4.9 Teleflex 4.9.1 Company Details 4.9.2 Teleflex Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.9.3 Teleflex Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.9.4 Main Business Overview 4.9.5 Teleflex News 4.10 Mylan 4.10.1 Company Details 4.10.2 Mylan Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification 4.10.3 Mylan Benign Prostatic Hyperplasia Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.10.4 Main Business Overview 4.10.5 Mylan News 5 Global Benign Prostatic Hyperplasia Devices Sales Categorized by Regions 5.1 Global Benign Prostatic Hyperplasia Devices Revenue, Sales and Market Share by Regions 5.1.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Regions (2017-2022) 5.1.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Regions (2017-2022) 5.2 North America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 5.3 Europe Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 5.4 Asia-pacific Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 5.5 South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 5.6 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 6 North America Benign Prostatic Hyperplasia Devices Market Size Categorized by Countries 6.1 North America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries 6.1.1 North America Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) 6.1.2 North America Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) 6.1.3 United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 6.1.4 Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 6.1.5 Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 6.2 North America Benign Prostatic Hyperplasia Devices Revenue (Value) by Manufacturers 6.3 North America Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2017-2022) 6.4 North America Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2017-2022) 7 Europe Benign Prostatic Hyperplasia Devices Market Size Categorized by Countries 7.1 Europe Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries 7.1.1 Europe Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) 7.1.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) 7.1.3 Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 7.1.4 UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 7.1.5 France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 7.1.6 Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 7.1.7 Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 7.1.8 Spain Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 7.2 Europe Benign Prostatic Hyperplasia Devices Revenue (Value) by Manufacturers 7.3 Europe Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2017-2022) 7.4 Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2017-2022) 8 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Size Categorized by Countries 8.1 Asia-pacific Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries 8.1.1 Asia-pacific Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) 8.1.2 Asia-pacific Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) 8.1.3 China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 8.1.4 South Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 8.1.5 Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 8.1.6 Australia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 8.1.7 India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 8.1.8 Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 8.2 Asia-pacific Benign Prostatic Hyperplasia Devices Revenue (Value) by Manufacturers 8.3 Asia-pacific Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2017-2022) 8.4 Asia-pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2017-2022) 9 South America Benign Prostatic Hyperplasia Devices Market Size Categorized by Countries 9.1 South America Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries 9.1.1 South America Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) 9.1.2 South America Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) 9.1.3 Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 9.2 South America Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2017-2022) 9.3 South America Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2017-2022) 10 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Size Categorized by Countries 10.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) 10.1.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) 10.1.3 GCC Countries Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 10.1.4 Turkey Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 10.1.5 Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 10.1.6 South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) 10.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales and Market Share by Type 10.3 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2017-2022) 11 Global Benign Prostatic Hyperplasia Devices Market Segment by Type 11.1 Global Benign Prostatic Hyperplasia Devices Revenue, Sales and Market Share by Type (2017-2022) 11.1.1 Global Benign Prostatic Hyperplasia Devices Sales and Market Share by Type (2017-2022) 11.1.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Type (2017-2022) 11.2 Drugs Sales Growth Rate and Price 11.2.1 Global Drugs Sales Growth Rate (2017-2022) 11.2.2 Global Drugs Price (2017-2022) 11.3 Devices Sales Growth Rate and Price 11.3.1 Global Devices Sales Growth Rate (2017-2022) 11.3.2 Global Devices Price (2017-2022) 12 Global Benign Prostatic Hyperplasia Devices Market Segment by Application 12.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2017-2022) 12.2 Hospitals Sales Growth Rate (2017-2022) 12.3 Clinics Sales Growth Rate (2017-2022) 12.4 Others Sales Growth Rate (2017-2022) 13 Global Benign Prostatic Hyperplasia Devices Market Forecast 13.1 Global Benign Prostatic Hyperplasia Devices Revenue, Sales and Growth Rate (2022-2027) 13.2 Benign Prostatic Hyperplasia Devices Market Forecast by Regions (2022-2027) 13.2.1 North America Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) 13.2.2 Europe Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) 13.2.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) 13.2.4 South America Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) 13.2.5 Middle East & Africa Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) 13.3 Benign Prostatic Hyperplasia Devices Market Forecast by Type (2022-2027) 13.3.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2022-2027) 13.3.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2022-2027) 13.4 Benign Prostatic Hyperplasia Devices Market Forecast by Application (2022-2027) 13.4.1 Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2022-2027) 13.4.2 Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2022-2027) 14 Market Analysis 14.1.1 Market overview 14.1.2 Market Opportunities 14.1.3 Market Risk 14.1.4 Market Driving Force 14.1.5 Porter's Five Forces Analysis 14.1.6 SWOT Analysis 15 Benign Prostatic Hyperplasia Devices Industry Related Market Analysis 15.1 Upstream Analysis 15.1.1 Macro Analysis of Upstream Markets 15.1.2 Key Players in Upstream Markets 15.1.3 Upstream Market Trend Analysis 15.1.4 Benign Prostatic Hyperplasia Devices Manufacturing Cost Analysis 15.2 Downstream Market Analysis 15.2.1 Macro Analysis of Down Markets 15.2.2 Key Players in Down Markets 15.2.3 Downstream Market Trend Analysis 15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures Figure Product Picture Benign Prostatic Hyperplasia Devices Figure Market Concentration Ratio and Market Maturity Analysis of Benign Prostatic Hyperplasia Devices Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Part of Our External Database Figure Key Executives Interviewed Table Global Benign Prostatic Hyperplasia Devices Market Size by Type Figure Global Market Share of Benign Prostatic Hyperplasia Devices by Type in 2021 Figure Drugs Picture Figure Devices Picture Table Global Benign Prostatic Hyperplasia Devices Market Size (Volume) by Application Figure Hospitals Picture Figure Clinics Picture Figure Others Picture Table Global Benign Prostatic Hyperplasia Devices Comparison by Regions (M USD) 2017-2027 Figure Global Benign Prostatic Hyperplasia Devices Market Size (Million US$) (2017-2027) Figure North America Benign Prostatic Hyperplasia Devices Revenue (Million US$) Growth Rate (2017-2027) Figure Europe Benign Prostatic Hyperplasia Devices Revenue (Million US$) Growth Rate (2017-2027) Figure Asia-pacific Benign Prostatic Hyperplasia Devices Revenue (Million US$) Growth Rate (2017-2027) Figure South America Benign Prostatic Hyperplasia Devices Revenue (Million US$) Growth Rate (2017-2027) Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Revenue (Million US$) Growth Rate (2017-2027) Table Business Impact Assessment - Covid-19 Table Market Trends and Benign Prostatic Hyperplasia Devices Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Benign Prostatic Hyperplasia Devices Sales by Manufacturer (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturer in 2021 Table Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2021 Table Global Benign Prostatic Hyperplasia Devices Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2021 Figure Top 10 Benign Prostatic Hyperplasia Devices Manufacturer (Revenue) Market Share in 2021 Table Date of Key Manufacturers Enter into Benign Prostatic Hyperplasia Devices Market Table Key Manufacturers Benign Prostatic Hyperplasia Devices Product Type Table Mergers & Acquisitions Planning Table Pfizer Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Pfizer Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2022 Table Pfizer Main Business Table Pfizer Recent Development Table Teva Pharmaceutical Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Teva Pharmaceutical Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical 2017-2022 Table Teva Pharmaceutical Main Business Table Teva Pharmaceutical Recent Development Table Boston Scientific Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Boston Scientific Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Boston Scientific 2017-2022 Table Boston Scientific Main Business Table Boston Scientific Recent Development Table Sanofi Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Sanofi Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2017-2022 Table Sanofi Main Business Table Sanofi Recent Development Table Allergan Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Allergan Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2017-2022 Table Allergan Main Business Table Allergan Recent Development Table GlaxoSmithKline Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of GlaxoSmithKline Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2017-2022 Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Eli Lilly Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Eli Lilly Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2017-2022 Table Eli Lilly Main Business Table Eli Lilly Recent Development Table Cardinal Health Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Cardinal Health Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cardinal Health 2017-2022 Table Cardinal Health Main Business Table Cardinal Health Recent Development Table Teleflex Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Teleflex Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teleflex 2017-2022 Table Teleflex Main Business Table Teleflex Recent Development Table Mylan Company Profile Table Benign Prostatic Hyperplasia Devices Product Introduction, Application and Specification of Mylan Table Benign Prostatic Hyperplasia Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2017-2022 Table Mylan Main Business Table Mylan Recent Development Figure Global Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2017-2022) Table Global Benign Prostatic Hyperplasia Devices Sales by Regions (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Regions in 2021 Table Global Benign Prostatic Hyperplasia Devices Revenue by Regions (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Regions in 2021 Figure North America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Europe Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Asia-pacific Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure South America Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure North America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2017-2022) Table North America Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) Table North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2017-2022) Figure North America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2021 Table North America Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) Table North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2017-2022) Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2021 Figure United States Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Canada Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Mexico Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Table North America Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2021) Figure North America Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2021 Table North America Benign Prostatic Hyperplasia Devices Sales by Type (2017-2022) Table North America Benign Prostatic Hyperplasia Devices Sales Share by Type (2017-2022) Table North America Benign Prostatic Hyperplasia Devices Sales by Application (2017-2022) Table North America Benign Prostatic Hyperplasia Devices Sales Share by Application (2017-2022) Figure Europe Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2017-2022) Table Europe Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) Table Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2017-2022) Figure Europe Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2021 Table Europe Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) Table Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2017-2022) Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2021 Figure Germany Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure UK Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure France Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Russia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Italy Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Spain Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Table Europe Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2021) Figure Europe Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2021 Table Europe Benign Prostatic Hyperplasia Devices Sales by Type (2017-2022) Table Europe Benign Prostatic Hyperplasia Devices Sales Share by Type (2017-2022) Table Europe Benign Prostatic Hyperplasia Devices Sales by Application (2017-2022) Table Europe Benign Prostatic Hyperplasia Devices Sales Share by Application (2017-2022) Figure Asia-pacific Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2017-2022) Table Asia-pacific Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) Table Asia-pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2017-2022) Figure Asia-pacific Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2021 Table Asia-pacific Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) Table Asia-pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2017-2022) Figure Asia-pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2021 Figure China Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure South Korea Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Japan Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Australia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure India Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Southeast Asia Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Table Asia-pacific Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2021) Figure Asia-pacific Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturer in 2021 Table Asia-pacific Benign Prostatic Hyperplasia Devices Sales by Type (2017-2022) Table Asia-pacific Benign Prostatic Hyperplasia Devices Sales Share by Type (2017-2022) Table Asia-pacific Benign Prostatic Hyperplasia Devices Sales by Application (2017-2022) Table Asia-pacific Benign Prostatic Hyperplasia Devices Sales Share by Application (2017-2022) Figure South America Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2017-2022) Figure South America Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2019 Table South America Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2017-2022) Figure South America Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2019 Figure Brazil Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Sales by Type (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Sales Share by Type (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Revenue by Type (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Revenue Share by Type (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Sales by Application (2017-2022) Table South America Benign Prostatic Hyperplasia Devices Sales Share by Application (2017-2022) Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales (Volume) by Countries (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries (2017-2022) Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Market Share by Countries in 2019 Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Countries (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries (2017-2022) Figure Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Market Share by Countries in 2019 Figure GCC Countries Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Turkey Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure Egypt Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Figure South Africa Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Type (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Share by Type (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue by Type (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Revenue Share by Type (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales by Application (2017-2022) Table Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Share by Application (2017-2022) Table Global Benign Prostatic Hyperplasia Devices Sales by Type (2017-2022) Table Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type in 2021 Table Global Benign Prostatic Hyperplasia Devices Revenue by Type (2017-2022) Table Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type in 2019 Figure Global Drugs Sales Growth Rate (2017-2022) Figure Global Drugs Price (2017-2022) Figure Global Devices Sales Growth Rate (2017-2022) Figure Global Devices Price (2017-2022) Table Global Benign Prostatic Hyperplasia Devices Sales by Application (2017-2022) Table Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application in 2021 Figure Global Hospitals Sales Growth Rate (2017-2022) Figure Global Clinics Sales Growth Rate (2017-2022) Figure Global Others Sales Growth Rate (2017-2022) Figure Global Benign Prostatic Hyperplasia Devices Sales and Growth Rate (2022-2027) Figure Global Benign Prostatic Hyperplasia Devices Revenue and Growth Rate (2022-2027) Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Regions (2017-2022) Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Regions (2017-2022) Figure North America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) Figure Europe Sales Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) Figure Asia-Pacific Sales Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) Figure South America Sales Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) Figure Middle East & Africa Sales Benign Prostatic Hyperplasia Devices Market Forecast (2022-2027) Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Type (2022-2027) Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Type (2022-2027) Table Global Benign Prostatic Hyperplasia Devices Sales Forecast by Application (2022-2027) Table Global Benign Prostatic Hyperplasia Devices Market Share Forecast by Application (2022-2027) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Benign Prostatic Hyperplasia Devices Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure Author List

Pfizer Teva Pharmaceutical Boston Scientific Sanofi Allergan GlaxoSmithKline Eli Lilly Cardinal Health Teleflex Mylan